322 related articles for article (PubMed ID: 31926377)
41. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
[TBL] [Abstract][Full Text] [Related]
42. Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy.
Zhang P; Huang H; Banerjee S; Clarkson GJ; Ge C; Imberti C; Sadler PJ
Angew Chem Int Ed Engl; 2019 Feb; 58(8):2350-2354. PubMed ID: 30552796
[TBL] [Abstract][Full Text] [Related]
43. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
[TBL] [Abstract][Full Text] [Related]
44. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
45. In-vitro and In-vivo Photocatalytic Cancer Therapy with Biocompatible Iridium(III) Photocatalysts.
Huang C; Liang C; Sadhukhan T; Banerjee S; Fan Z; Li T; Zhu Z; Zhang P; Raghavachari K; Huang H
Angew Chem Int Ed Engl; 2021 Apr; 60(17):9474-9479. PubMed ID: 33434379
[TBL] [Abstract][Full Text] [Related]
46. Cyclometalated Iridium(III) Complexes as Mitochondria-targeting Photosensitizers against Cisplatin-resistant Cells.
Xiong K; Zhou Y; Lin X; Kou J; Lin M; Guan R; Chen Y; Ji L; Chao H
Photochem Photobiol; 2022 Jan; 98(1):85-91. PubMed ID: 33617666
[TBL] [Abstract][Full Text] [Related]
47. Near-infrared AIE-active phosphorescent iridium(III) complex for mitochondria-targeted photodynamic therapy.
Pan ZY; Liang BF; Zhi YS; Yao DH; Li CY; Wu HQ; He L
Dalton Trans; 2023 Jan; 52(5):1291-1300. PubMed ID: 36625001
[TBL] [Abstract][Full Text] [Related]
48. Studies of anticancer activity in vivo and in vitro behaviors of liposomes encapsulated iridium(III) complex.
Gu Y; Wen H; Zhang Y; Bai L; Zhou Y; Zhang H; Tian L; Hao J; Liu Y
J Biol Inorg Chem; 2021 Feb; 26(1):109-122. PubMed ID: 33475857
[TBL] [Abstract][Full Text] [Related]
49. Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell Inhibition.
Yuan H; Han Z; Chen Y; Qi F; Fang H; Guo Z; Zhang S; He W
Angew Chem Int Ed Engl; 2021 Apr; 60(15):8174-8181. PubMed ID: 33656228
[TBL] [Abstract][Full Text] [Related]
50. Dinuclear phosphorescent rhenium(I) complexes as potential anticancer and photodynamic therapy agents.
Pan ZY; Cai DH; He L
Dalton Trans; 2020 Aug; 49(33):11583-11590. PubMed ID: 32766642
[TBL] [Abstract][Full Text] [Related]
51. Development of Wireless Power-Transmission-Based Photodynamic Therapy for the Induction of Cell Death in Cancer Cells by Cyclometalated Iridium(III) Complexes.
Yokoi K; Yasuda Y; Kanbe A; Imura T; Aoki S
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771099
[TBL] [Abstract][Full Text] [Related]
52. Photophysical and Photobiological Properties of Dinuclear Iridium(III) Bis-tridentate Complexes.
Liu B; Monro S; Lystrom L; Cameron CG; Colón K; Yin H; Kilina S; McFarland SA; Sun W
Inorg Chem; 2018 Aug; 57(16):9859-9872. PubMed ID: 30091916
[TBL] [Abstract][Full Text] [Related]
53. Novel half-sandwich iridium OˆC (carbene)-Complexes: In vitro and in vivo tumor growth suppression and pro-apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes.
Xu Z; Zhang Y; Zhang S; Jia X; Zhong G; Yang Y; Du Q; Li J; Liu Z
Cancer Lett; 2019 Apr; 447():75-85. PubMed ID: 30673591
[TBL] [Abstract][Full Text] [Related]
54. Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
Ouyang M; Zeng L; Huang H; Jin C; Liu J; Chen Y; Ji L; Chao H
Dalton Trans; 2017 May; 46(20):6734-6744. PubMed ID: 28488721
[TBL] [Abstract][Full Text] [Related]
55. Metal Complexes for Two-Photon Photodynamic Therapy: A Cyclometallated Iridium Complex Induces Two-Photon Photosensitization of Cancer Cells under Near-IR Light.
McKenzie LK; Sazanovich IV; Baggaley E; Bonneau M; Guerchais V; Williams JA; Weinstein JA; Bryant HE
Chemistry; 2017 Jan; 23(2):234-238. PubMed ID: 27740703
[TBL] [Abstract][Full Text] [Related]
56. Increasing anticancer effect in vitro and vivo of liposome-encapsulated iridium(III) complexes on BEL-7402 cells.
Zhang Y; Fei W; Zhang H; Zhou Y; Tian L; Hao J; Yuan Y; Li W; Liu Y
J Inorg Biochem; 2021 Dec; 225():111622. PubMed ID: 34624670
[TBL] [Abstract][Full Text] [Related]
57. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir
Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G
Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086
[TBL] [Abstract][Full Text] [Related]
58. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer agents.
Xiong K; Chen Y; Ouyang C; Guan RL; Ji LN; Chao H
Biochimie; 2016 Jun; 125():186-94. PubMed ID: 27039888
[TBL] [Abstract][Full Text] [Related]
59. Metal/N-heterocyclic carbene complexes: opportunities for the development of anticancer metallodrugs.
Cisnetti F; Gautier A
Angew Chem Int Ed Engl; 2013 Nov; 52(46):11976-8. PubMed ID: 24115500
[No Abstract] [Full Text] [Related]
60. A new near-infrared phosphorescent iridium(III) complex conjugated to a xanthene dye for mitochondria-targeted photodynamic therapy.
Wu Y; Wu J; Wong WY
Biomater Sci; 2021 Jul; 9(14):4843-4853. PubMed ID: 33998610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]